Rohin Mhatre is of REPLIGEN CORP. Currently has a direct ownership of 4,019 shares of RGEN, which is worth approximately $512,301. The most recent transaction as insider was on May 15, 2025, when has been sold 973 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.02K
31.94% 3M change
31.94% 12M change
Total Value Held $512,301

Rohin Mhatre Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2025
BUY
Grant, award, or other acquisition
-
973 Added 19.49%
4,019 Common Stock
May 16 2024
BUY
Grant, award, or other acquisition
-
701 Added 18.71%
3,046 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
686 Added 22.63%
2,345 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
1,202 Added 42.01%
1,659 Common Stock
May 13 2021
BUY
Grant, award, or other acquisition
-
457 Added 50.0%
457 Common Stock
RM

Rohin Mhatre

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN